Cancer is principally considered a genetic disease, and numerous mutations are thought essential to drive its growth. However, the existence of genomically stable cancers and the emergence of mutations in genes that encode chromatin remodelers raise the possibility that perturbation of chromatin structure and epigenetic regulation are capable of driving cancer formation. Here we sequenced the exomes of 35 rhabdoid tumors, highly aggressive cancers of early childhood characterized by biallelic loss of SMARCB1, a subunit of the SWI/SNF chromatin remodeling complex. We identified an extremely low rate of mutation, with loss of SMARCB1 being essentially the sole recurrent event. Indeed, in 2 of the cancers there were no other identified mutations. Our results demonstrate that high mutation rates are dispensable for the genesis of cancers driven by mutation of a chromatin remodeling complex. Consequently, cancer can be a remarkably genetically simple disease.
Ryan S. Lee, Chip Stewart, Scott L. Carter, Lauren Ambrogio, Kristian Cibulskis, Carrie Sougnez, Michael S. Lawrence, Daniel Auclair, Jaume Mora, Todd R. Golub, Jaclyn A. Biegel, Gad Getz, Charles W.M. Roberts
Title and authors | Publication | Year |
---|---|---|
SMARCB1 ‐deficient malignant melanocytic uveal tumours: a new neural crest‐derived tumour entity with SMARCB1 ‐related germline predisposition
Cyrta J, Masliah\u2010Planchon J, Hoare O, Brillet R, Andrianteranagna M, Sohier P, Cardoen L, Bouchoucha Y, Filser M, Goncalves A, Caly M, Fréneaux P, Stefanaki K, Pefkianaki M, Moschovi M, Matet A, Cassoux N, Lumbroso\u2010Le Rouic L, Gauthier\u2010Villars M, Stern M, Vincent\u2010Salomon A, Rodrigues M, Bourdeaut F |
The Journal of Pathology | 2025 |
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Perotti D, O'Sullivan MJ, Walz AL, Davick J, Al-Saadi R, Benedetti DJ, Brzezinski J, Ciceri S, Cost NG, Dome JS, Drost J, Evageliou N, Furtwängler R, Graf N, Maschietto M, Mullen EA, Murphy AJ, Ortiz MV, van der Beek JN, Verschuur A, Wegert J, Williams R, Spreafico F, Geller JI, van den Heuvel-Eibrink MM, Hong AL |
Nature reviews. Urology | 2025 |
SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials
Shakerdi AL, Pidgeon GP |
Metabolites | 2025 |
SIRT2 regulates the SMARCB1 loss-driven differentiation block in ATRT
Alimova I, Wang D, DeSisto J, Danis E, Lakshmanachetty S, Prince E, Murdock G, Pierce A, Donson A, Balakrishnan I, Serkova N, Lin H, Foreman NK, Dahl N, Venkataraman S, Vibhakar R |
Molecular cancer research : MCR | 2025 |
Epigenetic regulation in cancer.
Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X, Zhou F, Xiao R, Luo X, You L, Zhao Y |
2024 | |
Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1
Jones CA, Wang J, Evans JR, Sisk HR, Womack CB, Liu Q, Tansey WP, Weissmiller AM |
Cancers | 2024 |
Translational Aspects of Epithelioid Sarcoma – Current Consensus
Grunewald TG, Postel-Vinay S, Nakayama RT, Berlow NE, Bolzicco A, Cerullo V, Dermawan JK, Frezza AM, Italiano A, Jin JX, Loarer FL, Martin-Broto J, Pecora A, Perez-Martinez A, Tam YB, Tirode F, Trama A, Pasquali S, Vescia M, ortmann L, Wortmann M, Yoshida A, Webb K, Huang PH, Keller C, Antonescu CR |
Clinical cancer research | 2024 |
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, Zhu Z, Hansen BS, Donovan KA, Hunkeler M, Rosikiewicz W, Wu Z, McReynolds MG, Roy Burman SS, Schmoker AM, Mageed N, Brown SA, Mobley RJ, Partridge JF, Stewart EA, Pruett-Miller SM, Nabet B, Peng J, Gray NS, Fischer ES, Roberts CWM |
Nature | 2024 |
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
Bielamowicz KJ, Littrell MB, Albert GW, Parker LS, Jayappa S, Aldape K, Gokden M |
Journal of Neuro-Oncology | 2024 |
Developmental origins shape the paediatric cancer genome.
Chen X, Yang W, Roberts CWM, Zhang J |
Nature reviews. Cancer | 2024 |
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Kim SS, Moghe M, Rait A, Donaldson K, Harford JB, Chang EH |
International Journal of Nanomedicine | 2024 |
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression
Mittal P, Myers JA, Carter RD, Radko-Juettner S, Malone HA, Rosikiewicz W, Robertson AN, Zhu Z, Narayanan IV, Hansen BS, Parrish M, Bhanu NV, Mobley RJ, Rehg JE, Xu B, Drosos Y, Pruett-Miller SM, Ljungman M, Garcia BA, Wu G, Partridge JF, Roberts CW |
Nature Communications | 2024 |
Chromatin remodellers as therapeutic targets.
Malone HA, Roberts CWM |
Nature reviews. Drug discovery | 2024 |
The Biological Clock of Liver Metabolism in Metabolic Dysfunction-Associated Steatohepatitis Progression to Hepatocellular Carcinoma
Rajan PK, Udoh UA, Finley R, Pierre SV, Sanabria J |
Biomedicines | 2024 |
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Golbourn B, Ho B, Bondoc A, Luck A, Fan X, Richardson E, Marcellus R, Prakesch M, Halbert M, Agrawal N, Smith C, Huang A, Rutka JT |
Neuro-oncology | 2024 |
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
Merk DJ, Tsiami F, Hirsch S, Walter B, Haeusser LA, Maile JD, Stahl A, Jarboui MA, Lechado-Terradas A, Klose F, Babaei S, Admard J, Casadei N, Roggia C, Spohn M, Schittenhelm J, Singer S, Schüller U, Piccioni F, Persky NS, Claassen M, Tatagiba M, Kahle PJ, Root DE, Templin M, Tabatabai G |
Genome Biology | 2024 |
Progress Toward Epigenetic Targeted Therapies for Childhood Cancer
Liapodimitri A, Tetens AR, Craig-Schwartz J, Lunsford K, Skalitzky KO, Koldobskiy MA |
Cancers | 2024 |
Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs
Nguyen LT, Hains AE, Aziz-Zanjani MO, Dalsass M, Farooqee SB, Lu Y, Jackson PK, Van Rechem C |
The Journal of Biological Chemistry | 2024 |
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors
Fleischmann LS, Nemes K, Glaser S, Kouroukli AG, Boros M, Bens S, Dahlum S, Kretzmer H, Oyen F, Gerss J, Hasselblatt M, Frühwald MC, Siebert R |
Neuro-Oncology | 2024 |
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Kes MM, Morales-Rodriguez F, Zaal EA, de Souza T, Proost N, van de Ven M, van den Heuvel-Eibrink MM, Jansen JW, Berkers CR, Drost J |
Cell Reports Medicine | 2024 |
Lineage-Selective Dependencies in Pediatric Cancers
Ritter KE, Durbin AD |
Cold Spring Harbor perspectives in medicine | 2024 |
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Alva E, Rubens J, Chi S, Rosenberg T, Reddy A, Raabe EH, Margol A |
Neoplasia (New York, N.Y.) | 2023 |
SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression
Walhart TA, Vacca B, Hepperla AJ, Hamad SH, Petrongelli J, Wang Y, McKean EL, Moksa M, Cao Q, Yip S, Hirst M, Weissman BE |
The American Journal of Pathology | 2023 |
(mis)-Targeting of SWI/SNF complex(es) in cancer.
Reddy D, Bhattacharya S, Workman JL |
Cancer metastasis reviews | 2023 |
Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications
Dang DD, Rosenblum JS, Shah AH, Zhuang Z, Doucet-O\u2019Hare TT |
Cancers | 2023 |
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
Navickas SM, Giles KA, Brettingham-Moore KH, Taberlay PC |
Oncogene | 2023 |
Current advances in immunotherapy for atypical teratoid rhabdoid tumor (ATRT)
Tran S, Plant-Fox AS, Chi SN, Narendran A |
Neuro-Oncology Practice | 2023 |
Modeling human brain rhabdoid tumor by inactivating tumor suppressor genes in induced pluripotent stem cells
Hua T, Xue Y, Sarker DB, Kiran S, Li Y, Sang QX |
Bioactive Materials | 2023 |
Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors.
Kuwahara Y, Iehara T, Matsumoto A, Okuda T |
Cancer Medicine | 2023 |
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
Lobón-Iglesias MJ, Andrianteranagna M, Han ZY, Chauvin C, Masliah-Planchon J, Manriquez V, Tauziede-Espariat A, Turczynski S, Bouarich-Bourimi R, Frah M, Dufour C, Blauwblomme T, Cardoen L, Pierron G, Maillot L, Guillemot D, Reynaud S, Bourneix C, Pouponnot C, Surdez D, Bohec M, Baulande S, Delattre O, Piaggio E, Ayrault O, Waterfall JJ, Servant N, Beccaria K, Dangouloff-Ros V, Bourdeaut F |
Nature Communications | 2023 |
Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor.
Wei CH, Wang E, Sadimin E, Rodriguez-Rodriguez L, Agulnik M, Yoon J, LoBello J, Szelinger S, Anderson C |
Gynecologic Oncology Reports | 2023 |
Extradural malignant rhabdoid tumor of the spine in children: A case-based review.
Vigneul E, Rooijakkers H, Joris V, Daoud L, Van Damme A, Raftopoulos C |
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery | 2023 |
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen VT, Tessema M, Weissman BE |
Cancer treatment and research | 2023 |
A Rare Case of Rhabdoid Pancreatic Carcinoma: Prolonged Disease-Free Survival Following Upfront Resection and Adjuvant Chemotherapy
Land G, Van Haeringen B, Cooper C, Andelkovic V, O'Rourke T |
Cureus | 2023 |
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
A Florian, C Woodley, J Wang, B Grieb, M Slota, K Guerrazzi, C Hsu, B Matlock, D Flaherty, S Lorey, S Fesik, G Howard, Q Liu, A Weissmiller, W Tansey |
2022 | |
Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors
I Alimova, D Wang, E Danis, A Pierce, A Donson, N Serkova, K Madhavan, S Lakshmanachetty, I Balakrishnan, N Foreman, S Mitra, S Venkataraman, R Vibhakar |
International journal of oncology | 2022 |
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
C Ngo, S Postel-Vinay |
Biomedicines | 2022 |
The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells
K Moe, J Maxwell, J Wang, C Jones, G Csaki, A Florian, A Romer, D Bryant, A Farone, Q Liu, W Tansey, A Weissmiller |
Oncogenesis | 2022 |
Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors
Groves A, Clymer J, Filbin MG |
Pharmaceuticals | 2022 |
Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review
Lak NS, van der Kooi EJ, Enciso-Martinez A, Lozano-Andrés E, Otto C, Wauben MH, Tytgat GA |
Frontiers in Oncology | 2022 |
Recent Advances in Renal Medullary Carcinoma
Su Y, Hong AL |
International journal of molecular sciences | 2022 |
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial
Parsons DW, Janeway KA, Patton DR, Winter CL, Coffey B, Williams PM, Roy-Chowdhuri S, Tsongalis GJ, Routbort M, Ramirez NC, Saguilig L, Piao J, Alonzo TA, Berg SL, Fox E, Hawkins DS, Abrams JS, Mooney M, Takebe N, Tricoli JV, Seibel NL |
Journal of Clinical Oncology | 2022 |
Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
Tourigny DS, Zucker M, Kim M, Russo P, Coleman J, Lee CH, Carlo MI, Chen YB, Hakimi AA, Kotecha RR, Reznik E |
Frontiers in Oncology | 2022 |
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation
Jones CA, Tansey WP, Weissmiller AM |
2022 | |
Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Ferrari A, Brennan B, Casanova M, Corradini N, Berlanga P, Schoot RA, Ramirez-Villar GL, Safwat A, Guillen Burrieza G, Dall\u2019Igna P, Alaggio R, Lyngsie Hjalgrim L, Gatz SA, Orbach D, van Noesel MM |
Cancer management and research | 2022 |
NSD1 mediates antagonism between SWI/SNF and Polycomb complexes and is required for transcriptional activation upon EZH2 inhibition
Drosos Y, Myers JA, Xu B, Mathias KM, Beane EC, Radko-Juettner S, Mobley RJ, Larsen ME, Piccioni F, Ma X, Low J, Hansen BS, Peters ST, Bhanu NV, Dhanda SK, Chen T, Upadhyaya SA, Pruett-Miller SM, Root DE, Garcia BA, Partridge JF, Roberts CW |
Molecular Cell | 2022 |
How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
Cipri S, Abenavoli L, Boccuto L, Del Baldo G, Mastronuzzi A |
2022 | |
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Islam SM, Díaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, He Y, Vella M, Wang J, Teague JW, Clapham P, Moody S, Senkin S, Li YR, Riva L, Zhang T, Gruber AJ, Steele CD, Otlu B, Khandekar A, Abbasi A, Humphreys L, Syulyukina N, Brady SW, Alexandrov BS, Pillay N, Zhang J, Adams DJ, Martincorena I, Wedge DC, Landi MT, Brennan P, Stratton MR, Rozen SG, Alexandrov LB |
2022 | |
Dedifferentiation and in vivo reprogramming of committed cells in wound repair (Review).
Guo Y, Wu W, Yang X, Fu X |
Molecular medicine reports | 2022 |
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK, Singer S, Tap WD, Nacev BA, Chi P, Wexler LH, Ortiz MV, Gounder M, Antonescu CR |
Modern Pathology | 2022 |
Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets
Rechberger JS, Nesvick CL, Daniels DJ |
Expert opinion on therapeutic targets | 2022 |
Synergy between Toxoplasma gondii type I Δ GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
YC Zhu, HM Elsheikha, JH Wang, S Fang, JJ He, XQ Zhu, J Chen |
Journal for ImmunoTherapy of Cancer | 2021 |
Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications
S Chen, X Deng, H Sheng, Y Rong, Y Zheng, Y Zhang, J Lin |
Molecular Therapy — Nucleic Acids | 2021 |
In vitro Modeling of Embryonal Tumors
L Custers, I Paassen, J Drost |
Frontiers in Cell and Developmental Biology | 2021 |
Global Chromatin Changes Resulting from Single-Gene Inactivation—The Role of SMARCB1 in Malignant Rhabdoid Tumor
C Kenny, E OMeara, M Ulaş, K Hokamp, MJ OSullivan |
Cancers | 2021 |
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
A Marcu, A Schlosser, A Keupp, N Trautwein, P Johann, M Wölfl, J Lager, CM Monoranu, JS Walz, LM Henkel, J Krauß, M Ebinger, M Schuhmann, UW Thomale, T Pietsch, E Klinker, PG Schlegel, F Oyen, Y Reisner, HG Rammensee, M Eyrich |
Journal for ImmunoTherapy of Cancer | 2021 |
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
J Li, TS Mulvihill, L Li, JJ Barrott, ML Nelson, L Wagner, IC Lock, A Pozner, SL Lambert, BB Ozenberger, MB Ward, AH Grossmann, T Liu, A Banito, BR Cairns, KB Jones |
Cancer Discovery | 2021 |
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
MT Elghetany, JM Ho, LH Shi-Qi, S Karthik, JM Su, Q Lin, YC Du, J Shen, WY Chow, CC Lau, A Adesina, A Major, A Erdreich-Epstein, KM Hui, XN Li, WY Teo |
Scientific Reports | 2021 |
Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy
WC Chong, WS Jayasekara, VG Vaghjiani, S Parackal, C Sun, D Popovski, EM Algar, R Firestein, PJ Wood, S Khan, A Huang, DM Ashley, P Downie, JE Cain |
Cancers | 2021 |
DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker
N Azizgolshani, CL Petersen, Y Chen, JJ Levy, LA Salas, L Perreard, LN Nguyen, BC Christensen |
Clinical Epigenetics | 2021 |
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
GD Baldo, R Carta, I Alessi, P Merli, E Agolini, M Rinelli, L Boccuto, GM Milano, A Serra, A Carai, F Locatelli, A Mastronuzzi |
Frontiers in Oncology | 2021 |
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
SA Upadhyaya, GW Robinson, A Onar-Thomas, BA Orr, P Johann, G Wu, CA Billups, RG Tatevossian, SK Dhanda, A Srinivasan, A Broniscer, I Qaddoumi, A Vinitsky, GT Armstrong, AE Bendel, T Hassall, S Partap, PG Fisher, JR Crawford, M Chintagumpala, E Bouffet, S Gururangan, R Mostafavi, RP Sanders, P Klimo, Z Patay, DJ Indelicato, KE Nichols, FA Boop, TE Merchant, M Kool, DW Ellison, A Gajjar |
Clinical cancer research | 2021 |
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
M Garcia-Moure, M Gonzalez-Huarriz, S Labiano, E Guruceaga, E Bandres, M Zalacain, L Marrodan, C de Andrea, M Villalba, N Martinez-Velez, V Laspidea, M Puigdelloses, JG Perez-Larraya, I Iñigo-Marco, R Stripecke, JA Chan, EH Raabe, M Kool, C Gomez-Manzano, J Fueyo, A Patiño-García, MM Alonso |
Clinical cancer research | 2020 |
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
J Theruvath, E Sotillo, CW Mount, CM Graef, A Delaidelli, S Heitzeneder, L Labanieh, S Dhingra, A Leruste, RG Majzner, P Xu, S Mueller, DW Yecies, MA Finetti, D Williamson, PD Johann, M Kool, S Pfister, M Hasselblatt, MC Frühwald, O Delattre, D Surdez, F Bourdeaut, S Puget, S Zaidi, SS Mitra, S Cheshier, PH Sorensen, M Monje, CL Mackall |
Nature Medicine | 2020 |
The SWI/SNF complex in cancer — biology, biomarkers and therapy
P Mittal, CW Roberts |
Nature Reviews Clinical Oncology | 2020 |
SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors
P Panwalkar, D Pratt, C Chung, D Dang, P Le, D Martinez, JM Bayliss, KS Smith, M Adam, S Potter, PA Northcott, L Mascarenhas, J Shows, B Pawel, A Margol, A Huang, AR Judkins, S Venneti |
Neuro-Oncology | 2020 |
Targeting epigenetics in sarcomas through EZH2 inhibition
A Italiano |
Journal of Hematology & Oncology | 2020 |
Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors
LM Hoffman, EA Richardson, B Ho, A Margol, A Reddy, L Lafay-Cousin, S Chi, I Slavc, A Judkins, M Hasselblatt, F Bourdeaut, MC Frühwald, R Vibhakar, E Bouffet, A Huang |
Neuro-Oncology | 2020 |
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
P Msaouel, GG Malouf, X Su, H Yao, DN Tripathi, M Soeung, J Gao, P Rao, C Coarfa, CJ Creighton, JP Bertocchio, S Kunnimalaiyaan, AS Multani, J Blando, R He, DD Shapiro, L Perelli, S Srinivasan, F Carbone, PG Pilié, M Karki, RN Seervai, BH Vokshi, D Lopez-Terrada, EH Cheng, X Tang, W Lu, II Wistuba, TC Thompson, I Davidson, V Giuliani, K Schlacher, A Carugo, TP Heffernan, P Sharma, JA Karam, CG Wood, CL Walker, G Genovese, NM Tannir |
Cancer Cell | 2020 |
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
CL Nesvick, L Lafay-Cousin, A Raghunathan, E Bouffet, AA Huang, DJ Daniels |
Journal of Neuro-Oncology | 2020 |
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
AD Parisian, T Koga, S Miki, PD Johann, M Kool, JR Crawford, FB Furnari |
Genes & development | 2020 |
Structural Insights into the Evolutionarily Conserved BAF Chromatin Remodeling Complex
RD Marcum, AA Reyes, Y He |
Biology : open access journal | 2020 |
The epigenomics of sarcoma
BA Nacev, KB Jones, AM Intlekofer, JS Yu, CD Allis, WD Tap, M Ladanyi, TO Nielsen |
Nature Reviews Cancer | 2020 |
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
TP Howard, EM Oberlick, MG Rees, TE Arnoff, MT Pham, L Brenan, M DoCarmo, AL Hong, G Kugener, HC Chou, Y Drosos, KM Mathias, P Ramos, B Seashore-Ludlow, AO Giacomelli, X Wang, BB Freeman, K Blankenship, L Hoffmann, HL Tiv, PC Gokhale, CM Johannessen, EA Stewart, SL Schreiber, WC Hahn, CW Roberts |
Clinical cancer research | 2020 |
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
A Perla, L Fratini, PS Cardoso, C Nör, AT Brunetto, AL Brunetto, CB de Farias, M Jaeger, R Roesler |
Frontiers in Cell and Developmental Biology | 2020 |
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
D Holdhof, PD Johann, M Spohn, M Bockmayr, S Safaei, P Joshi, J Masliah-Planchon, B Ho, M Andrianteranagna, F Bourdeaut, A Huang, M Kool, SA Upadhyaya, AE Bendel, D Indenbirken, WD Foulkes, JW Bush, D Creytens, U Kordes, MC Frühwald, M Hasselblatt, U Schüller |
Acta Neuropathologica | 2020 |
Human Pluripotent Stem Cell Fate Regulation by SMARCB1
I Carmel-Gross, E Levy, L Armon, O Yaron, HW Ben-Asher, A Urbach |
Stem Cell Reports | 2020 |
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
SJ Forrest, A Al-Ibraheemi, D Doan, A Ward, CM Clinton, J Putra, RS Pinches, C Kadoch, SN Chi, SG DuBois, PJ Leavey, NR LeBoeuf, E Mullen, N Collins, AJ Church, KA Janeway |
Clinical cancer research | 2020 |
Evolving insights: how DNA repair pathways impact cancer evolution
J Zhou, XA Zhou, N Zhang, J Wang |
Cancer biology & medicine | 2020 |
Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven Medulloblastoma
Bethany, L Veo, Etienne Danis, Angela Pierce, Ismail Sola, Dong Wang, Nicholas K Foreman, Jian Jin, Anqi Ma, Natalie Serkova, Sujatha Venkataraman, Rajeev Vibhakar |
JCI Insight | 2019 |
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
TP Howard, TE Arnoff, MR Song, AO Giacomelli, X Wang, AL Hong, NV Dharia, S Wang, F Vazquez, MT Pham, AM Morgan, F Wachter, GH Bird, G Kugener, EM Oberlick, MG Rees, HL Tiv, JH Hwang, KH Walsh, A Cook, JM Krill-Burger, A Tsherniak, PC Gokhale, PJ Park, K Stegmaier, LD Walensky, WC Hahn, CW Roberts |
Cancer research | 2019 |
Inhibition of MYC by the SMARCB1 tumor suppressor
AM Weissmiller, J Wang, SL Lorey, GC Howard, E Martinez, Q Liu, WP Tansey |
Nature Communications | 2019 |
Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
RC Smith, V Tabar |
Cell Stem Cell | 2019 |
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
A Carugo, R Minelli, L Sapio, M Soeung, F Carbone, FS Robinson, J Tepper, Z Chen, S Lovisa, M Svelto, S Amin, S Srinivasan, ED Poggetto, S Loponte, F Puca, P Dey, GG Malouf, X Su, L Li, D Lopez-Terrada, D Rakheja, AJ Lazar, GJ Netto, P Rao, A Sgambato, A Maitra, DN Tripathi, CL Walker, JA Karam, TP Heffernan, A Viale, CW Roberts, P Msaouel, NM Tannir, GF Draetta, G Genovese |
Cancer Cell | 2019 |
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
KA Orlando, V Nguyen, JR Raab, T Walhart, BE Weissman |
Expert Review of Anticancer Therapy | 2019 |
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
AL Hong, YY Tseng, JA Wala, WJ Kim, BD Kynnap, MB Doshi, G Kugener, GJ Sandoval, TP Howard, J Li, X Yang, M Tillgren, M Ghandi, A Sayeed, R Deasy, A Ward, B McSteen, KM Labella, P Keskula, A Tracy, C Connor, CM Clinton, AJ Church, BD Crompton, KA Janeway, BV Hare, D Sandak, O Gjoerup, P Bandopadhayay, PA Clemons, SL Schreiber, DE Root, PC Gokhale, SN Chi, EA Mullen, CW Roberts, C Kadoch, R Beroukhim, KL Ligon, JS Boehm, WC Hahn |
eLife | 2019 |
BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors
X Wang, S Wang, EC Troisi, TP Howard, JR Haswell, BK Wolf, WH Hawk, P Ramos, EM Oberlick, EP Tzvetkov, F Vazquez, WC Hahn, PJ Park, CW Roberts |
Nature Communications | 2019 |
A case of intraplacental gestational choriocarcinoma; characterised by the methylation pattern of the early placenta and an absence of driver mutations
P Savage, D Monk, JR Mora, N van der Westhuizen, J Rauw, A Tinker, W Robinson, Q Song, MJ Seckl, RA Fisher |
BMC Cancer | 2019 |
Microfluidic epigenomic mapping technologies for precision medicine
C Deng, LB Naler, C Lu |
Lab on a Chip | 2019 |
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer
AP Bracken, GL Brien, CP Verrijzer |
Genes & development | 2019 |
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
JH Phi, CH Sun, SH Lee, S Lee, I Park, SA Choi, SH Park, JY Lee, KC Wang, SK Kim, H Yun, CK Park |
BMC Cancer | 2019 |
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine
SZ Wang, B Poore, J Alt, A Price, SJ Allen, AR Hanaford, H Kaur, BA Orr, BS Slusher, CG Eberhart, EH Raabe, JA Rubens |
Clinical cancer research | 2019 |
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors
EM Oberlick, MG Rees, B Seashore-Ludlow, F Vazquez, GM Nelson, NV Dharia, BA Weir, A Tsherniak, M Ghandi, JM Krill-Burger, RM Meyers, X Wang, P Montgomery, DE Root, JM Bieber, S Radko, JH Cheah, CS Hon, AF Shamji, PA Clemons, PJ Park, MA Dyer, TR Golub, K Stegmaier, WC Hahn, EA Stewart, SL Schreiber, CW Roberts |
Cell Reports | 2019 |
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
HJ Chun, PD Johann, K Milne, M Zapatka, A Buellesbach, N Ishaque, M Iskar, S Erkek, L Wei, B Tessier-Cloutier, J Lever, E Titmuss, JT Topham, R Bowlby, E Chuah, KL Mungall, Y Ma, AJ Mungall, RA Moore, MD Taylor, DS Gerhard, SJ Jones, A Korshunov, M Gessler, K Kerl, M Hasselblatt, MC Frühwald, EJ Perlman, BH Nelson, SM Pfister, MA Marra, M Kool |
Cell Reports | 2019 |
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors
MC Frühwald, M Hasselblatt, K Nemes, S Bens, M Steinbügl, PD Johann, K Kerl, P Hauser, E Quiroga, P Solano-Paez, V Biassoni, MJ Gil-da-Costa, M Perek-Polnik, M van de Wetering, D Sumerauer, J Pears, N Stabell, S Holm, H Hengartner, NU Gerber, M Grotzer, J Boos, M Ebinger, S Tippelt, W Paulus, R Furtwängler, P Hernáiz-Driever, H Reinhard, S Rutkowski, PG Schlegel, I Schmid, RD Kortmann, B Timmermann, M Warmuth-Metz, U Kordes, J Gerss, K Nysom, R Schneppenheim, R Siebert, M Kool, N Graf |
Neuro-Oncology | 2019 |
The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
EA Sweet-Cordero, JA Biegel |
Science | 2019 |
Cancer epigenetics: Moving forward
A Nebbioso, FP Tambaro, C DellAversana, L Altucci, JM Greally |
PLoS genetics | 2018 |
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
MJ McBride, JL Pulice, HC Beird, DR Ingram, AR DAvino, JF Shern, GW Charville, JL Hornick, RT Nakayama, EM Garcia-Rivera, DM Araujo, WL Wang, JW Tsai, M Yeagley, AJ Wagner, PA Futreal, J Khan, AJ Lazar, C Kadoch |
Cancer Cell | 2018 |
The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application
Y YAMADA, Y YAMADA |
Proceedings of the Japan Academy, Series B | 2018 |
The asymmetrically segregating lncRNA cherub is required for transforming stem cells into malignant cells
L Landskron, V Steinmann, F Bonnay, TR Burkard, J Steinmann, I Reichardt, H Harzer, AS Laurenson, H Reichert, JA Knoblich |
eLife | 2018 |
Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous
EM Pinto, D Hamideh, A Bahrami, BA Orr, T Lin, S Pounds, GP Zambetti, AS Pappo, A Gajjar, S Agnihotri, A Broniscer |
Acta Neuropathologica | 2018 |
Cherub versus brat
JA Malin, C Desplan |
eLife | 2018 |
The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex
S Sammak, MD Allen, N Hamdani, M Bycroft, G Zinzalla |
The FEBS journal | 2018 |
Case-based review: atypical teratoid/rhabdoid tumor
CL Nesvick, AA Rao, A Raghunathan, JA Biegel, DJ Daniels |
Neuro-Oncology Practice | 2018 |
Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
N Potter, L Jones, H Blair, S Strehl, CJ Harrison, M Greaves, L Kearney, LJ Russell |
Leukemia | 2018 |
Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers
R Groisberg, DS Hong, J Roszik, F Janku, AM Tsimberidou, M Javle, F Meric-Bernstam, V Subbiah |
Molecular cancer therapeutics | 2018 |
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution
S Venkatesan, C Swanton, BS Taylor, JF Costello |
Cold Spring Harbor Perspectives in Medicine | 2017 |
Integrating RNA sequencing into neuro-oncology practice
DS Rogawski, NA Vitanza, AC Gauthier, V Ramaswamy, C Koschmann |
Translational Research | 2017 |
Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib
S Vyse, F McCarthy, M Broncel, A Paul, JP Wong, A Bhamra, PH Huang |
Journal of Proteomics | 2017 |
Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model
Z Yang, M Jia, G Liu, H Hao, L Chen, G Li, S Liu, Y Li, CI Wu, X Lu, S Wang, CM Wong |
PloS one | 2017 |
Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex
P Sen, J Luo, A Hada, SG Hailu, ML Dechassa, J Persinger, S Brahma, S Paul, J Ranish, B Bartholomew |
Cell Reports | 2017 |
SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors
A Jeibmann, J Schulz, K Eikmeier, PD Johann, K Thiel, I Tegeder, O Ambrée, MC Frühwald, SM Pfister, M Kool, W Paulus, M Hasselblatt |
Journal of Neuro-Oncology | 2017 |
PGBD5 promotes site-specific oncogenic mutations in human tumors
AG Henssen, R Koche, J Zhuang, E Jiang, C Reed, A Eisenberg, E Still, IC MacArthur, E Rodríguez-Fos, S Gonzalez, M Puiggròs, AN Blackford, CE Mason, E Stanchina, M Gönen, AK Emde, M Shah, K Arora, C Reeves, ND Socci, E Perlman, CR Antonescu, CW Roberts, H Steen, E Mullen, SP Jackson, D Torrents, Z Weng, SA Armstrong, A Kentsis |
Nature Genetics | 2017 |
Modeling and Targeting MYC Genes in Childhood Brain Tumors
S Hutter, S Bolin, H Weishaupt, F Swartling |
Genes & development | 2017 |
Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment
C Dardis, J Yeo, K Milton, LS Ashby, KA Smith, S Mehta, E Youssef, J Eschbacher, K Tucker, L Dawes, N Lambie, E Algar, E Hovey |
Frontiers in neurology | 2017 |
The whole-genome landscape of medulloblastoma subtypes
PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, T Ehrenberger, S Gröbner, M Segura-Wang, T Zichner, VA Rudneva, HJ Warnatz, N Sidiropoulos, AH Phillips, S Schumacher, K Kleinheinz, SM Waszak, S Erkek, DT Jones, BC Worst, M Kool, M Zapatka, N Jäger, L Chavez, B Hutter, M Bieg, N Paramasivam, M Heinold, Z Gu, N Ishaque, C Jäger-Schmidt, CD Imbusch, A Jugold, D Hübschmann, T Risch, V Amstislavskiy, FG Gonzalez, UD Weber, S Wolf, GW Robinson, X Zhou, G Wu, D Finkelstein, Y Liu, FM Cavalli, B Luu, V Ramaswamy, X Wu, J Koster, M Ryzhova, YJ Cho, SL Pomeroy, C Herold-Mende, M Schuhmann, M Ebinger, LM Liau, J Mora, RE McLendon, N Jabado, T Kumabe, E Chuah, Y Ma, RA Moore, AJ Mungall, KL Mungall, N Thiessen, K Tse, T Wong, SJ Jones, O Witt, T Milde, AV Deimling, D Capper, A Korshunov, ML Yaspo, R Kriwacki, A Gajjar, J Zhang, R Beroukhim, E Fraenkel, JO Korbel, B Brors, M Schlesner, R Eils, MA Marra, SM Pfister, MD Taylor, P Lichter |
Nature | 2017 |
Emerging Opportunities for Target Discovery in Rare Cancers
T Sharifnia, AL Hong, CA Painter, JS Boehm |
Cell Chemical Biology | 2017 |
Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
J Vitte, F Gao, G Coppola, AR Judkins, M Giovannini |
Nature Communications | 2017 |
Epigenetic Alterations in Bone and Soft Tissue Tumors:
J Wojcik, K Cooper |
Advances in Anatomic Pathology | 2017 |
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
W Richer, J Masliah-Planchon, N Clement, I Jimenez, L Maillot, D Gentien, B Albaud, W Chemlali, C Galant, F Larousserie, P Boudou-Rouquette, A Leruste, C Chauvin, ZY Han, JM Coindre, P Varlet, P Freneaux, D Ranchère-Vince, O Delattre, F Bourdeaut |
Oncotarget | 2017 |
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
HC Hodges, BZ Stanton, K Cermakova, CY Chang, EL Miller, JG Kirkland, WL Ku, V Veverka, K Zhao, GR Crabtree |
Nature Structural & Molecular Biology | 2017 |
Transposase-driven rearrangements in human tumors
SC Mack, H Suzuki, MD Taylor |
Nature Genetics | 2017 |
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
ZY Han, W Richer, P Fréneaux, C Chauvin, C Lucchesi, D Guillemot, C Grison, D Lequin, G Pierron, J Masliah-Planchon, A Nicolas, D Ranchère-Vince, P Varlet, S Puget, I Janoueix-Lerosey, O Ayrault, D Surdez, O Delattre, F Bourdeaut |
Nature Communications | 2016 |
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
X Wang, RS Lee, BH Alver, JR Haswell, S Wang, J Mieczkowski, Y Drier, SM Gillespie, TC Archer, JN Wu, EP Tzvetkov, EC Troisi, SL Pomeroy, JA Biegel, MY Tolstorukov, BE Bernstein, PJ Park, CW Roberts |
Nature Genetics | 2016 |
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
C Hodges, JG Kirkland, GR Crabtree |
Cold Spring Harbor Perspectives in Medicine | 2016 |
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
K Giannikou, IA Malinowska, TJ Pugh, R Yan, YY Tseng, C Oh, J Kim, ME Tyburczy, Y Chekaluk, Y Liu, N Alesi, GA Finlay, CL Wu, S Signoretti, M Meyerson, G Getz, JS Boehm, EP Henske, DJ Kwiatkowski, GS Barsh |
PLoS genetics | 2016 |
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
AP Feinberg, MA Koldobskiy, A Göndör |
Nature Reviews Genetics | 2016 |
MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation
A Stojanova, WB Tu, R Ponzielli, M Kotlyar, PK Chan, PC Boutros, F Khosravi, I Jurisica, B Raught, LZ Penn |
Cell cycle (Georgetown, Tex.) | 2016 |
Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
HJ Chun, EL Lim, A Heravi-Moussavi, S Saberi, KL Mungall, M Bilenky, A Carles, K Tse, I Shlafman, K Zhu, JQ Qian, DL Palmquist, A He, W Long, R Goya, M Ng, VG LeBlanc, E Pleasance, N Thiessen, T Wong, E Chuah, YJ Zhao, JE Schein, DS Gerhard, MD Taylor, AJ Mungall, RA Moore, Y Ma, SJ Jones, EJ Perlman, M Hirst, MA Marra |
Cancer Cell | 2016 |
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, F Holst, TI Zack, HM Werner, KM Staby, M Rosenberg, IM Stefansson, K Kusonmano, A Chevalier, KK Mauland, J Trovik, C Krakstad, M Giannakis, E Hodis, K Woie, L Bjorge, OK Vintermyr, JA Wala, MS Lawrence, G Getz, SL Carter, R Beroukhim, HB Salvesen |
Nature Genetics | 2016 |
INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases
JK Wasserman, BC Dickson, B Perez-Ordonez, JR de Almeida, JC Irish, I Weinreb |
Head and Neck Pathology | 2016 |
Distinct mutation accumulation rates among tissues determine the variation in cancer risk
D Hao, L Wang, L Di |
Scientific Reports | 2016 |
Prognostic factors and survival in non-central nervous system rhabdoid tumors
BA Farber, N Shukla, II Lim, JM Murphy, MP la Quaglia |
Journal of Pediatric Surgery | 2016 |
Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma
A Mariño-Enríquez, JV Bovée |
Surgical Pathology Clinics | 2016 |
Secondary EWSR1 gene abnormalities in SMARCB1 -deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results: EWSR1 Abnormalities in SMARCB1 -Deleted Tumors
SC Huang, L Zhang, YS Sung, CL Chen, YC Kao, NP Agaram, CR Antonescu |
Genes Chromosomes and Cancer | 2016 |
A Molecular Take on Malignant Rhabdoid Tumors
M Tang, RG Verhaak |
Trends in Cancer | 2016 |
Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
MC Frühwald, JA Biegel, F Bourdeaut, CW Roberts, SN Chi |
Neuro-Oncology | 2016 |
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
W Chang, AS Brohl, R Patidar, S Sindiri, JF Shern, JS Wei, YK Song, ME Yohe, B Gryder, S Zhang, KA Calzone, N Shivaprasad, X Wen, TC Badgett, M Miettinen, KR Hartman, JC League-Pascual, TN Trahair, BC Widemann, MS Merchant, RN Kaplan, JC Lin, J Khan |
Clinical cancer research | 2016 |
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, JD Norman, P Guilhamon, L Garzia, NR Agamez, M Lu, TS Chan, D Picard, P Antonellis, DA Khuong-Quang, AC Planello, C Zeller, D Barsyte-Lovejoy, L Lafay-Cousin, L Letourneau, M Bourgey, M Yu, DM Gendoo, M Dzamba, M Barszczyk, T Medina, AN Riemenschneider, AS Morrissy, YS Ra, V Ramaswamy, M Remke, CP Dunham, S Yip, H Ng, JQ Lu, V Mehta, S Albrecht, J Pimentel, JA Chan, GR Somers, CC Faria, L Roque, M Fouladi, LM Hoffman, AS Moore, Y Wang, SA Choi, JR Hansford, D Catchpoole, DK Birks, NK Foreman, D Strother, A Klekner, L Bognár, M Garami, P Hauser, T Hortobágyi, B Wilson, J Hukin, AS Carret, TE van Meter, EI Hwang, A Gajjar, SH Chiou, H Nakamura, H Toledano, I Fried, D Fults, T Wataya, C Fryer, DD Eisenstat, K Scheinemann, AJ Fleming, DL Johnston, J Michaud, S Zelcer, R Hammond, S Afzal, DA Ramsay, N Sirachainan, S Hongeng, N Larbcharoensub, RG Grundy, RR Lulla, JR Fangusaro, H Druker, U Bartels, R Grant, D Malkin, CJ McGlade, T Nicolaides, T Tihan, J Phillips, J Majewski, A Montpetit, G Bourque, GD Bader, AT Reddy, GY Gillespie, M Warmuth-Metz, S Rutkowski, U Tabori, M Lupien, M Brudno, U Schüller, T Pietsch, AR Judkins, CE Hawkins, E Bouffet, SK Kim, PB Dirks, MD Taylor, A Erdreich-Epstein, CH Arrowsmith, DD de Carvalho, JT Rutka, N Jabado, A Huang |
Cancer Cell | 2016 |
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
JP Wong, JR Todd, MA Finetti, F McCarthy, M Broncel, S Vyse, MT Luczynski, S Crosier, KA Ryall, K Holmes, LS Payne, F Daley, P Wai, A Jenks, B Tanos, AC Tan, RC Natrajan, D Williamson, PH Huang |
Cell Reports | 2016 |
Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22
HM Byers, MP Adam, A LaCroix, SE Leary, B Cole, WB Dobyns, HC Mefford |
American journal of medical genetics. Part A | 2016 |
The SWI/SNF Complex Protein Snr1 Is a Tumor Suppressor in Drosophila Imaginal Tissues
G Xie, H Chen, D Jia, Z Shu, WH Palmer, YC Huang, X Zeng, SX Hou, R Jiao, WM Deng |
Cancer research | 2016 |
Genetics of Bladder Malignant Tumors in Childhood
A Zangari, J Zaini, C Gulia |
Current genomics | 2015 |
Evolutionary Determinants of Cancer
M Greaves |
Cancer Discovery | 2015 |
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
A Brock, S Krause, DE Ingber |
Nature Reviews Cancer | 2015 |
Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics
MA Smith, GH Reaman |
Pediatric Clinics of North America | 2015 |
Oncotator: Cancer Variant Annotation Tool
AH Ramos, L Lichtenstein, M Gupta, MS Lawrence, TJ Pugh, G Saksena, M Meyerson, G Getz |
Human Mutation | 2015 |
The effects of chromatin organization on variation in mutation rates in the genome
KD Makova, RC Hardison |
Nature Reviews Genetics | 2015 |
Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies
LM Hoffman, R Salloum, M Fouladi |
Current Neurology and Neuroscience Reports | 2015 |
Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations
F Yang, E Petsalaki, T Rolland, DE Hill, M Vidal, FP Roth, M Singh |
PLoS computational biology | 2015 |
A Rare Case of Undifferentiated Carcinoma of the Colon with Rhabdoid Features: A Case Report and Review of the Literature
E Moussaly, JP Atallah |
Case Reports in Oncological Medicine | 2015 |
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
J Noujaim, K Thway, Z Bajwa, A Bajwa, RG Maki, RL Jones, C Keller |
Frontiers in Oncology | 2015 |
Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome Sequencing
Y Koh, I Park, CH Sun, S Lee, H Yun, CK Park, SH Park, JK Park, SH Lee |
Translational oncology | 2015 |
Atypical teratoid rhabdoid tumors of the posterior fossa in children
AJ DiPatri, ST Sredni, G Grahovac, T Tomita |
Child's Nervous System | 2015 |
Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
J Darr, A Klochendler, S Isaac, T Geiger, A Eden |
Molecular Cancer | 2015 |
Exome Sequencing of an Adult Pituitary Atypical Teratoid Rhabdoid Tumor
S Biswas, M Wood, A Joshi, N Bown, L Strain, T Martinsson, J Campbell, A Ashworth, A Swain |
Frontiers in Oncology | 2015 |
An epigenetic gateway to brain tumor cell identity
SC Mack, CG Hubert, TE Miller, MD Taylor, JN Rich |
Nature Neuroscience | 2015 |
Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency
J Sandgren, S Holm, AM Marino, J Asmundsson, P Grillner, M Nistér, TD de Ståhl |
BioMed Research International | 2015 |
Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
JM Ng, D Martinez, ED Marsh, Z Zhang, E Rappaport, M Santi, T Curran |
Cancer research | 2015 |
Biology and Treatment of Rhabdoid Tumor
Geller JI, Roth JJ, Biegel JA |
Critical Reviews in Oncogenesis | 2015 |
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
Fahiminiya S, Witkowski L, Nadaf J, Carrot-Zhang J, Goudie C, Hasselblatt M, Johann P, Kool M, Lee RS, Gayden T, Roberts CW, Biegel JA, Jabado N, Majewski J, Foulkes WD |
Oncotarget | 2015 |
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
KH Kim, CW Roberts |
Cancer Genetics | 2014 |
Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
KC Helming, X Wang, CW Roberts |
Cancer Cell | 2014 |
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, M Gallo, L Garzia, K Zayne, X Zhang, V Ramaswamy, N Jäger, DT Jones, M Sill, TJ Pugh, M Ryzhova, KM Wani, DJ Shih, R Head, M Remke, SD Bailey, T Zichner, CC Faria, M Barszczyk, S Stark, H Seker-Cin, S Hutter, P Johann, S Bender, V Hovestadt, T Tzaridis, AM Dubuc, PA Northcott, J Peacock, KC Bertrand, S Agnihotri, FM Cavalli, I Clarke, K Nethery-Brokx, CL Creasy, SK Verma, J Koster, X Wu, Y Yao, T Milde, P Sin-Chan, J Zuccaro, L Lau, S Pereira, P Castelo-Branco, M Hirst, MA Marra, SS Roberts, D Fults, L Massimi, YJ Cho, TV Meter, W Grajkowska, B Lach, AE Kulozik, A Deimling, O Witt, SW Scherer, X Fan, KM Muraszko, M Kool, SL Pomeroy, N Gupta, J Phillips, A Huang, U Tabori, C Hawkins, D Malkin, PN Kongkham, WA Weiss, N Jabado, JT Rutka, E Bouffet, JO Korbel, M Lupien, KD Aldape, GD Bader, R Eils, P Lichter, PB Dirks, SM Pfister, A Korshunov, MD Taylor |
Nature | 2014 |
Diffuse intrinsic pontine glioma: a reassessment
NJ Robison, MW Kieran |
Journal of Neuro-Oncology | 2014 |
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material: SMARCB1 Homozygous Deletions in Epithelioid Sarcoma
FL Loarer, L Zhang, CD Fletcher, A Ribeiro, S Singer, A Italiano, A Neuville, A Houlier, F Chibon, JM Coindre, CR Antonescu |
Genes Chromosomes and Cancer | 2014 |
Advances in Cancer Research
K Mayes, Z Qiu, A Alhazmi, JW Landry |
Advances in cancer research | 2014 |
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, E Tomiak, D Grynspan, E Saloustros, J Nadaf, B Rivera, C Gilpin, E Castellsagué, R Silva-Smith, F Plourde, M Wu, A Saskin, M Arseneault, RG Karabakhtsian, EA Reilly, FR Ueland, A Margiolaki, K Pavlakis, SM Castellino, J Lamovec, HJ Mackay, LM Roth, TM Ulbright, TA Bender, V Georgoulias, M Longy, A Berchuck, M Tischkowitz, I Nagel, R Siebert, CJ Stewart, J Arseneau, WG McCluggage, BA Clarke, Y Riazalhosseini, M Hasselblatt, J Majewski, WD Foulkes |
Nature Genetics | 2014 |
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
S Venneti, M Santi, MM Felicella, D Yarilin, JJ Phillips, LM Sullivan, D Martinez, A Perry, PW Lewis, CB Thompson, AR Judkins |
Acta Neuropathologica | 2014 |
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
NJ Roberts, L Zhang, F Janku, A Collins, RY Bai, V Staedtke, AW Rusk, D Tung, M Miller, J Roix, KV Khanna, R Murthy, RS Benjamin, T Helgason, AD Szvalb, JE Bird, S Roy-Chowdhuri, HH Zhang, Y Qiao, B Karim, J McDaniel, A Elpiner, A Sahora, J Lachowicz, B Phillips, A Turner, MK Klein, G Post, LA Diaz, GJ Riggins, N Papadopoulos, KW Kinzler, B Vogelstein, C Bettegowda, DL Huso, M Varterasian, S Saha, S Zhou |
Science Translational Medicine | 2014 |
SWI/SNF chromatin remodeling complexes and cancer: AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS)
JA Biegel, TM Busse, BE Weissman |
American Journal of Medical Genetics Part C Seminars in Medical Genetics | 2014 |
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
D Rakheja, KS Chen, Y Liu, AA Shukla, V Schmid, TC Chang, S Khokhar, JE Wickiser, NJ Karandikar, JS Malter, JT Mendell, JF Amatruda |
Nature Communications | 2014 |
The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation
AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, L Hurd, L Chen, JF Shern, H Liao, X Wen, J Gerard, JS Kim, JA Guerrero, I Machado, DH Wai, P Picci, T Triche, AE Horvai, M Miettinen, JS Wei, D Catchpool, A Llombart-Bosch, T Waldman, J Khan |
PLoS genetics | 2014 |
Wnt pathway in atypical teratoid rhabdoid tumors
M Chakravadhanula, CN Hampton, P Chodavadia, V Ozols, L Zhou, D Catchpoole, J Xu, A Erdreich-Epstein, RD Bhardwaj |
Neuro-Oncology | 2014 |
Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer
Y Yamada, H Haga, Y Yamada |
Stem Cells Translational Medicine | 2014 |
SNF5/INI1 Deficiency Redefines Chromatin Remodeling Complex Composition during Tumor Development
D Wei, D Goldfarb, S Song, C Cannon, F Yan, D Sakellariou-Thompson, M Emanuele, MB Major, BE Weissman, Y Kuwahara |
Molecular cancer research : MCR | 2014 |
Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor
F Jamshidi, E Pleasance, Y Li, Y Shen, K Kasaian, R Corbett, P Eirew, A Lum, P Pandoh, Y Zhao, JE Schein, RA Moore, R Rassekh, DG Huntsman, M Knowling, H Lim, DJ Renouf, SJ Jones, MA Marra, TO Nielsen, J Laskin, S Yip |
The oncologist | 2014 |
Loss of Smarc Proteins Impairs Cerebellar Development
N Moreno, C Schmidt, J Ahlfeld, J Poschl, S Dittmar, SM Pfister, M Kool, K Kerl, U Schuller |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2014 |
Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion
KR Bosse, AR Shukla, B Pawel, KR Chikwava, M Santi, L Tooke, K Castagna, JA Biegel, R Bagatell |
Cancer Genetics | 2014 |
Tumours outside the mutation box
R Versteeg |
Nature | 2014 |
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, Orr BA, Eberhart CG, Biegel JA, Raabe EH |
Oncotarget | 2014 |
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors.
Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, Reisman D |
Oncotarget | 2014 |
The genomic landscape of small intestine neuroendocrine tumors
Michaela Banck, Rahul Kanwar, Amit Kulkarni, Ganesh Boora, Franziska Metge, Benjamin Kipp, Lizhi Zhang, Erik Thorland, Kay Minn, Ramesh Tentu, Bruce Eckloff, Eric Wieben, Yanhong Wu, Julie Cunningham, David Nagorney, Judith Gilbert, Matthew Ames, Andreas Beutler |
Journal of Clinical Investigation | 2013 |
Rhabdoid Tumors: An Initial Clue to the Role of Chromatin Remodeling in Cancer: Rhabdoid Tumors and the Role of Chromatin Remodeling in Cancer
RS Lee, CW Roberts |
Brain Pathology | 2013 |
Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer--Mechanisms and Potential Therapeutic Insights
X Wang, JR Haswell, CW Roberts |
Clinical cancer research | 2013 |
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
K Cibulskis, MS Lawrence, SL Carter, A Sivachenko, D Jaffe, C Sougnez, S Gabriel, M Meyerson, ES Lander, G Getz |
Nature Biotechnology | 2013 |
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, SL Carter, K Cibulskis, M Hanna, A Kiezun, J Kim, MS Lawrence, L Lichenstein, A McKenna, CS Pedamallu, AH Ramos, E Shefler, A Sivachenko, C Sougnez, C Stewart, A Ally, I Birol, R Chiu, RD Corbett, M Hirst, SD Jackman, B Kamoh, AH Khodabakshi, M Krzywinski, A Lo, RA Moore, KL Mungall, J Qian, A Tam, N Thiessen, Y Zhao, KA Cole, M Diamond, SJ Diskin, YP Mosse, AC Wood, L Ji, R Sposto, T Badgett, WB London, Y Moyer, JM Gastier-Foster, MA Smith, JM Auvil, DS Gerhard, MD Hogarty, SJ Jones, ES Lander, SB Gabriel, G Getz, RC Seeger, J Khan, MA Marra, M Meyerson, JM Maris |
Nature Genetics | 2013 |
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
SK Knutson, NM Warholic, TJ Wigle, CR Klaus, CJ Allain, A Raimondi, MP Scott, R Chesworth, MP Moyer, RA Copeland, VM Richon, RM Pollock, KW Kuntz, H Keilhack |
Proceedings of the National Academy of Sciences | 2013 |
Die neue WHO-Klassifikation und aktuelle Ergebnisse in der Weichteiltumorpathologie
I Petersen |
Der Pathologe | 2013 |
Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
EL Mora-Blanco, Y Mishina, EJ Tillman, YJ Cho, CS Thom, SL Pomeroy, W Shao, CW Roberts |
Oncogene | 2013 |
Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters
MY Tolstorukov, CG Sansam, P Lu, EC Koellhoffer, KC Helming, BH Alver, EJ Tillman, JA Evans, BG Wilson, PJ Park, CW Roberts |
Proceedings of the National Academy of Sciences | 2013 |
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
K Kerl, D Ries, R Unland, C Borchert, N Moreno, M Hasselblatt, H Jürgens, M Kool, D Görlich, M Eveslage, M Jung, M Meisterernst, M Frühwald |
BMC Cancer | 2013 |
Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor
P Modena, I Sardi, M Brenca, L Giunti, AM Buccoliero, B Pollo, V Biassoni, L Genitori, M Antonelli, R Maestro, F Giangaspero, M Massimino |
BMC Cancer | 2013 |
NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
C Charbel, RH Fontaine, GG Malouf, A Picard, N Kadlub, N El-Murr, A How-Kit, X Su, A Coulomb-L'hermine, J Tost, S Mourah, S Aractingi, S Guégan |
Journal of Investigative Dermatology | 2013 |
Linking the SWI/SNF complex to prostate cancer
RS Lee, CW Roberts |
Nature Genetics | 2013 |
Landscape of genomic alterations in cervical carcinomas
AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, I Imaz-Rosshandler, TJ Pugh, AD Cherniack, L Ambrogio, K Cibulskis, B Bertelsen, S Romero-Cordoba, V Treviño, K Vazquez-Santillan, AS Guadarrama, AA Wright, MW Rosenberg, F Duke, B Kaplan, R Wang, E Nickerson, HM Walline, MS Lawrence, C Stewart, SL Carter, A McKenna, IP Rodriguez-Sanchez, M Espinosa-Castilla, K Woie, L Bjorge, E Wik, MK Halle, EA Hoivik, C Krakstad, NB Gabiño, GS Gómez-Macías, LD Valdez-Chapa, ML Garza-Rodríguez, G Maytorena, J Vazquez, C Rodea, A Cravioto, ML Cortes, H Greulich, CP Crum, DS Neuberg, A Hidalgo-Miranda, CR Escareno, LA Akslen, TE Carey, OK Vintermyr, SB Gabriel, HA Barrera-Saldaña, J Melendez-Zajgla, G Getz, HB Salvesen, M Meyerson |
Nature | 2013 |
Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors
S Wöhrle, A Weiss, M Ito, A Kauffmann, M Murakami, Z Jagani, A Thuery, B Bauer-Probst, F Reimann, C Stamm, A Pornon, V Romanet, V Guagnano, T Brümmendorf, WR Sellers, F Hofmann, CW Roberts, DG Porta |
PloS one | 2013 |
The SWI/SNF tumor suppressor complex
P Lu, CW Roberts |
Nucleus | 2013 |
A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer
R Deshpande, MK Asiedu, M Klebig, S Sutor, E Kuzmin, J Nelson, J Piotrowski, SH Shin, M Yoshida, M Costanzo, C Boone, DA Wigle, CL Myers |
Cancer research | 2013 |
SNF5 Reexpression in Malignant Rhabdoid Tumors Regulates Transcription of Target Genes by Recruitment of SWI/SNF Complexes and RNAPII to the Transcription Start Site of Their Promoters
Y Kuwahara, D Wei, J Durand, BE Weissman |
Molecular cancer research : MCR | 2013 |
The Potent Oncogene NPM-ALK Mediates Malignant Transformation of Normal Human CD4+ T Lymphocytes
Zhang Q, Wei F, Wang HY, Liu X, Roy D, Xiong QB, Jiang S, Medvec A, Danet-Desnoyers G, Watt C, Tomczak E, Kalos M, Riley JL, Wasik MA |
The American Journal of Pathology | 2013 |
Introduction
|
Brain Pathology | 2013 |
Medulloblastoma biology in the post-genomic era
TC Archer, SL Pomeroy |
Future Oncology | 2012 |
Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions
KF Ginn, A Gajjar |
Frontiers in Oncology | 2012 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |